OR13-04 Nucleoredoxin Regulates WNT Signaling During Pituitary Stem Cell Differentiation

Abstract Disclosure: M.L. Brinkmeier: None. S. Yang: None. L.Y. Cheung: None. S.P. O'Connell: None. D.K. Gutierrez: None. Y. Ho: None. E.C. Rhoads: None. S.A. Camper: None. S.W. Davis: None. Nucleoredoxin (Nxn) encodes a multi-functional enzyme with oxidoreductase activity that regulates signaling pathways and cellular processes in a redox-dependent manner. We noted that homozygous mouse Nxn mutants have pituitary dysmorphology at embryonic day 14.5 (e14.5), a time when differentiated hormone producing cells are beginning to emerge. We sought to identify the basis for pituitary dysmorphology in Nxn mutants and to determine whether hormone cell differentiation was affected.We characterized a null allele of Nxn, (Nxnem1(IMPC)J or Nxn-/-). We confirmed that Nxn deficient mice are viable until birth, but do not survive. At e18.5 mutants had completely penetrant cleft palate, and variable penetrance of facial clefting and eye abnormalities. We analyzed skeletal preparations and found significant shortening of the head, nasal bone, and mandible (p<0.05). There was incomplete ossification of the basisphenoid bone (p<0.01).We examined Nxn expression and pituitary development in Nxn-/-. Nxn transcripts were present in the developing posterior, intermediate, and anterior lobes of the pituitary gland between e11.5 and e17.5, with predominant expression in the Sox2 expressing stem cells and other progenitors. Pituitary dysmorphology was evident at e10.5 and persisted throughout gestation. We employed scRNA sequencing to assess the proportions of various cell types and to identify differentially expressed genes in dissected pituitary tissue at e14.5. Not all hormone genes are expressed at this stage; we used pseudotime analysis to assist in identifying the relationships between the cell clusters present. We found reduced expression of the non-canonical Wnt5a in the infundibulum, but normal expression of Fgf8. The fraction of cells obtained in the clusters expressing Prop1 and Pou1f1 was altered, and there were fewer differentiated thyrotropes. Pseudotime density suggests that the mutants have more cells in mid-trajectory and fewer cells at the end. We found reduced expression of the canonical WNT responsive gene Lef1. Gene expression changes were confirmed by immunohistochemistry. Using TIME-coExpress, we identified gene pairs with altered coexpression patterns in the absence of Nxn.In conclusion, Nxn is expressed in the developing ventral diencephalon and pituitary gland, and it is required for normal pituitary development. Nxn deficiency altered WNT signaling in the canonical and planar cell polarity pathways, and it reduced the progression of progenitor cells to differentiated cells. NXN mutations are reported in some individuals with Robinow syndrome, which involves skeletal dysplasia, short stature, craniofacial dysmorphisms, and incompletely penetrant heart and palate defects. Our results suggest patients with Robinow syndrome could benefit from evaluation by endocrinologists for pituitary structural imaging and hormone insufficiency. Presentation: Sunday, July 13, 2025

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-10-01
DOI
https://doi.org/10.1210/jendso/bvaf149.1476
Primary Topic
Nerve injury and regeneration
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

OR13-04 Nucleoredoxin Regulates WNT Signaling During Pituitary Stem Cell Differentiation

Shannon William Davis, Yen‐Yi Ho, Michelle L. Brinkmeier, Leonard Cheung et al.
Journal of the Endocrine Society
Nerve injury and regeneration
article

OR13-04 Nucleoredoxin Regulates WNT Signaling During Pituitary Stem Cell Differentiation

Shannon William Davis, Yen‐Yi Ho, Michelle L. Brinkmeier, Leonard Cheung, Shengyong Yang, Diana Gutiérrez, Sally Ann Camper, Sean P. O’Connell, Eve C Rhoads
article en

Abstract

Abstract Disclosure: M.L. Brinkmeier: None. S. Yang: None. L.Y. Cheung: None. S.P. O'Connell: None. D.K. Gutierrez: None. Y. Ho: None. E.C. Rhoads: None. S.A. Camper: None. S.W. Davis: None. Nucleoredoxin (Nxn) encodes a multi-functional enzyme with oxidoreductase activity that regulates signaling pathways and cellular processes in a redox-dependent manner. We noted that homozygous mouse Nxn mutants have pituitary dysmorphology at embryonic day 14.5 (e14.5), a time when differentiated hormone producing cells are beginning to emerge. We sought to identify the basis for pituitary dysmorphology in Nxn mutants and to determine whether hormone cell differentiation was affected.We characterized a null allele of Nxn, (Nxnem1(IMPC)J or Nxn-/-). We confirmed that Nxn deficient mice are viable until birth, but do not survive. At e18.5 mutants had completely penetrant cleft palate, and variable penetrance of facial clefting and eye abnormalities. We analyzed skeletal preparations and found significant shortening of the head, nasal bone, and mandible (p<0.05). There was incomplete ossification of the basisphenoid bone (p<0.01).We examined Nxn expression and pituitary development in Nxn-/-. Nxn transcripts were present in the developing posterior, intermediate, and anterior lobes of the pituitary gland between e11.5 and e17.5, with predominant expression in the Sox2 expressing stem cells and other progenitors. Pituitary dysmorphology was evident at e10.5 and persisted throughout gestation. We employed scRNA sequencing to assess the proportions of various cell types and to identify differentially expressed genes in dissected pituitary tissue at e14.5. Not all hormone genes are expressed at this stage; we used pseudotime analysis to assist in identifying the relationships between the cell clusters present. We found reduced expression of the non-canonical Wnt5a in the infundibulum, but normal expression of Fgf8. The fraction of cells obtained in the clusters expressing Prop1 and Pou1f1 was altered, and there were fewer differentiated thyrotropes. Pseudotime density suggests that the mutants have more cells in mid-trajectory and fewer cells at the end. We found reduced expression of the canonical WNT responsive gene Lef1. Gene expression changes were confirmed by immunohistochemistry. Using TIME-coExpress, we identified gene pairs with altered coexpression patterns in the absence of Nxn.In conclusion, Nxn is expressed in the developing ventral diencephalon and pituitary gland, and it is required for normal pituitary development. Nxn deficiency altered WNT signaling in the canonical and planar cell polarity pathways, and it reduced the progression of progenitor cells to differentiated cells. NXN mutations are reported in some individuals with Robinow syndrome, which involves skeletal dysplasia, short stature, craniofacial dysmorphisms, and incompletely penetrant heart and palate defects. Our results suggest patients with Robinow syndrome could benefit from evaluation by endocrinologists for pituitary structural imaging and hormone insufficiency. Presentation: Sunday, July 13, 2025

Journal of the Endocrine SocietyVol. 9(Supplement_1)
University of South Carolina (US), University of Michigan (US), Stony Brook School (US), Ann Arbor VA Medical Center (US), Stony Brook University (US)
Openalex Percentile: Top 67%
Nerve injury and regeneration
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.